Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
De Ioris MA, Castellano A, Ilari I, Garganese MC, Natali G, Inserra A, De Vito R, Ravà L, De Pasquale MD, Locatelli F, Donfrancesco A, Jenkner A.
De Ioris MA, et al. Among authors: jenkner a.
Eur J Cancer. 2011 Mar;47(4):572-8. doi: 10.1016/j.ejca.2010.10.023. Epub 2010 Nov 26.
Eur J Cancer. 2011.
PMID: 21112775